2022 Partners

Newcells Logo

Newcells Biotech

Newcells Biotech is a fast-growing team of global scientific and industry experts based in state-of-the-art facilities in the Helix Science Campus of Newcastle-upon-Tyne in the UK.  Our purpose is to bridge the gap between scientific discovery and patients and we make a difference by providing better predictions of clinical outcomes. Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung. 

www.newcellsbiotech.co.uk

Antaros

Antaros Medical

Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.

* magnetic resonance imaging

**positron emission tomography

 www.antarosmedical.com

gubra_logo-pos_new_green

Gubra

Gubra is a privately held biotech located in Denmark delivering scientific counselling, contract research services, and projects for co-development in five main areas: Obesity, diabetes, NASH, kidney, and heart diseases. Gubra experts cover pre-clinical disciplines such as in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS, bioinformatics and ex vivo assays. Gubra has a hybrid business model with a pipeline of early target and drug discovery programs aimed for partnering while also delivering preclinical services to customers.

www.gubra.dk